Late-Treated Phenylketonuria and Partial Reversibility of Intellectual Impairment-Reference-Cited by-同舟云学术

Late-Treated Phenylketonuria and Partial Reversibility of Intellectual Impairment

Published:2010-01 Issue:1 Volume:81 Page:200-211
ISSN:0009-3920
Container-title:Child Development
language:en
Short-container-title:

Author:

Grosse Scott D.

Publisher

Wiley

Subject

Developmental and Educational Psychology,Education,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1467-8624.2009.01389.x/fullpdf

Reference76 articles.

1. Neonatal screening and long-term follow-up of phenylketonuria: The French database;Abadie;Early Human Development,2001

2. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?;Anderson;Developmental Neuropsychology,2007

3. Neuropsychological functioning in children with early-treated phenylketonuria: Impact of white matter abnormalities;Anderson;Developmental Medicine and Child Neurology,2004

4. Intelligence in treated phenylketonuric children: A developmental study;Berman;Child Development,1966

5. Prevalence of four developmental disabilities among children aged 8 years-Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000;Bhasin;Morbidity and Mortality Weekly Report Surveillance Summaries,2006

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperactive GluN2B impairs neuroplasticity and cognition in phenylketonuria;2024-06-06

2. Newborn screening for congenital hypothyroidism and phenylketonuria—Beyond cost savings;The Journal of Pediatrics;2023-07

3. Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness;Children;2021-05-12

4. Monetary Valuation of Children’s Cognitive Outcomes in Economic Evaluations from a Societal Perspective: A Review;Children;2021-04-29

5. The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study;Orphanet Journal of Rare Diseases;2021-01-18